Tatva Chintan Pharma Chem (BOM:543321) LT-Debt-to-Total-Asset : 0.00 (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Tatva Chintan Pharma Chem LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Tatva Chintan Pharma Chem's long-term debt to total assests ratio for the quarter that ended in Jun. 2024 was 0.00.

Tatva Chintan Pharma Chem's long-term debt to total assets ratio stayed the same from Jun. 2023 (0.00) to Jun. 2024 (0.00).

Tatva Chintan Pharma Chem LT-Debt-to-Total-Asset Historical Data

The historical data trend for Tatva Chintan Pharma Chem's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tatva Chintan Pharma Chem LT-Debt-to-Total-Asset Chart

Tatva Chintan Pharma Chem Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.16

0.09

0.02

0.01

Tatva Chintan Pharma Chem Quarterly Data
	Mar19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial													-	-	-	-	-

Tatva Chintan Pharma Chem LT-Debt-to-Total-Asset Calculation

Tatva Chintan Pharma Chem's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (A: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2024 )	/	Total Assets (A: Mar. 2024 )
	=	6.39	/	8187.18
	=	0.00

Tatva Chintan Pharma Chem's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

LT Debt to Total Assets (Q: Jun. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Jun. 2024 )	/	Total Assets (Q: Jun. 2024 )
	=	0	/	0
	=

Tatva Chintan Pharma Chem (BOM:543321) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Tatva Chintan Pharma Chem LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Tatva Chintan Pharma Chem's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Tatva Chintan Pharma Chem Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Tatva Chintan Pharma Chem Ltd (BOM:543321) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

TATVA:India

Address

Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010

Website

https://www.tatvachintan.com

Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.

Tatva Chintan Pharma Chem Headlines

No Headlines